Gliomas

Gliomas are the primary brain tumors of the central nervous system. The prognosis, especially for high-grade gliomas, is dismal; the treatment of these tumors represents an unmet need in medicine. This book, contributed by an excellent team of clinicians and basic scientists, touches upon several cr...

Full description

Saved in:
Bibliographic Details
Other Authors: Debinski, Waldemar (Editor)
Format: Electronic Book Chapter
Language:English
Published: Australia Exon Publications 2021
Subjects:
Online Access:DOAB: download the publication
DOAB: description of the publication
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000naaaa2200000uu 4500
001 doab_20_500_12854_81837
005 20220522
003 oapen
006 m o d
007 cr|mn|---annan
008 20220522s2021 xx |||||o ||| 0|eng d
020 |a exonpublications.gliomas.2021 
020 |a 9780645001747 
040 |a oapen  |c oapen 
024 7 |a 10.36255/exonpublications.gliomas.2021  |c doi 
041 0 |a eng 
042 |a dc 
072 7 |a MJCL  |2 bicssc 
100 1 |a Debinski, Waldemar  |4 edt 
700 1 |a Debinski, Waldemar  |4 oth 
245 1 0 |a Gliomas 
260 |a Australia  |b Exon Publications  |c 2021 
300 |a 1 electronic resource (233 p.) 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
506 0 |a Open Access  |2 star  |f Unrestricted online access 
520 |a Gliomas are the primary brain tumors of the central nervous system. The prognosis, especially for high-grade gliomas, is dismal; the treatment of these tumors represents an unmet need in medicine. This book, contributed by an excellent team of clinicians and basic scientists, touches upon several critical aspects of glioma research and clinical therapies. There is a considerable emphasis on translational efforts. The 13 chapters of the book cover aspects of clinically-relevant models, glioma stem-like cells, IDH mutations, integrated approach for better patient outcome, abnormal cholesterol and other metabolic processes, bioinformatics for survival prediction, molecular signature for prognostication, neuro-functional monitoring during surgery, glioma-related epilepsy, and glioneuronal tumors along with various natural and synthetic drug candidates currently under evaluation. As such, the individual contributions provide a glimpse on the magnitude of challenges and potential solutions in a variety of research areas. This book will likely be interest to a wide audience seeking more information on challenges gliomas present to both scientists and clinicians. 
540 |a Creative Commons  |f https://creativecommons.org/licenses/by-nc-nd/4.0/  |2 cc  |4 https://creativecommons.org/licenses/by-nc-nd/4.0/ 
546 |a English 
650 7 |a MJCL  |2 bicssc 
653 |a Gliomas; Pre-Clinical Models for Glioblastoma; Novel Therapies for Glioblastomas; Mouse Models of Glioblastoma; Cancer Stem Cells in Pediatric Brain Tumors; IDH1 in Glioma; Improve Outcomes for Glioma Patients; Cholesterol Derivatives for Glioblastoma; Metabolic Therapy for Glioblastoma; Targeting Energy Metabolism for Glioblastoma; Resistance of Glioblastoma; Tumor-associated Edema; Curcumin for Gliomas; Survival Prediction in Gliomas; Molecular Markers of Gliomas; Prediction of Treatment and Prognosis of Gliomas; Brain Mapping for Gliomas; Neuropsychological Testing during Low-Grade Tumor Resection; Pathogenesis of Brain Tumor-Related Epilepsy; Management of Brain Tumor-Related Epilepsy; Glioneuronal Tumors 
856 4 0 |a www.oapen.org  |u https://exonpublications.com/index.php/exon/issue/view/15  |7 0  |z DOAB: download the publication 
856 4 0 |a www.oapen.org  |u https://directory.doabooks.org/handle/20.500.12854/81837  |7 0  |z DOAB: description of the publication